How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians

被引：0

作者：

Riccardi, Niccolo ^{[1
,2
]}

Occhineri, Sara ^{[1
,2
]}

Vanino, Elisa ^{[1
,3
]}

Antonello, Roberta Maria ^{[1
]}

Pontarelli, Agostina ^{[1
,4
]}

Saluzzo, Francesca ^{[1
,5
]}

Masini, Tiziana ^{[1
]}

Besozzi, Giorgio ^{[1
]}

Tadolini, Marina ^{[1
,6
,7
]}

Codecasa, Luigi ^{[1
,8
]}

机构：

[1] StopTB Italia ODV, I-20159 Milan, Italy

[2] Univ Pisana, Azienda Osped Univ Pisana, Azienda Osped, I-56124 Pisa, Italy

[3] Santa Maria Croci Hosp, Infect Dis Unit, AUSL Romagna, I-48100 Ravenna, Italy

[4] Cotugno Hosp, Azienda Osped Colli, Unit Resp Infect Dis, I-80131 Naples, Italy

[5] San Raffaele Univ, IRCCS San Raffaele Sci Inst, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy

[6] Infect Dis Unit, IRCCS Azienda Osped Univ Bologna, I-40138 Bologna, Italy

[7] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy

[8] ASST Grande Osped Metropolitano Niguarda, Villa Marelli Inst, Reg TB Reference Ctr, I-20159 Milan, Italy

来源：

ANTIBIOTICS-BASEL | 2023年 / 12卷 / 12期

关键词：

tuberculosis; pulmonary TB; drug susceptible; diagnosis; treatment; ANTITUBERCULOSIS DRUGS; DIABETES-MELLITUS; ADVERSE-REACTIONS; RISK-FACTORS; TB; RIFAMPIN; CARE; MANIFESTATIONS; HEPATOTOXICITY; PYRAZINAMIDE;

D O I：

10.3390/antibiotics12121733

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Tuberculosis (TB) remains one of the leading causes of morbidity and mortality worldwide and pulmonary TB (PTB) is the main variant responsible for fueling transmission of the infection. Effective treatment of drug-susceptible (DS) TB is crucial to avoid the emergence of Mycobacterium tuberculosis-resistant strains. In this narrative review, through a fictional suggestive case of DS PTB, we guide the reader in a step-by-step commentary to provide an updated review of current evidence in the management of TB, from diagnosis to post-treatment follow-up. World Health Organization and Centre for Diseases Control (CDC) guidelines for TB, as well as the updated literature, were used to support this manuscript.

引用

页数：17

共 119 条

[1] Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis [J].

Albanna, Amr S. ;

Smith, Benjamin M. ;

Cowan, Deanna ;

Menzies, Dick .

EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) :721-732

[2] Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis [J].

Alemu, Ayinalem ;

Bitew, Zebenay Workneh ;

Diriba, Getu ;

Seid, Getachew ;

Moga, Shewki ;

Abdella, Saro ;

Gashu, Emebet ;

Eshetu, Kirubel ;

Tollera, Getachew ;

Dangisso, Mesay Hailu ;

Gumi, Balako .

PLOS ONE, 2023, 18 (07)

[3] Diagnosis of tuberculosis in dialysis and kidney transplant patients [J].

Ali, Mahrukh ;

Dosani, Dhriti ;

Corbett, Richard ;

Johansson, Lina ;

Charif, Rawya ;

Kon, Onn Min ;

Duncan, Neill ;

Ashby, Damien .

HEMODIALYSIS INTERNATIONAL, 2022, 26 (03) :361-368

[4] Radiological manifestations of pulmonary tuberculosis [J].

Andreu, J ;

Cáceres, J ;

Pallisa, E ;

Martinez-Rodriguez, M .

EUROPEAN JOURNAL OF RADIOLOGY, 2004, 51 (02) :139-149

[5]

[Anonymous], 2013, Guideline: Nutritional Care and Support for Patients with Tuberculosis

[6]

[Anonymous], 2017, Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update

[7]

[Anonymous], 2017, WHO M TECHN EXP CONS

[8]

[Anonymous], 2023, Treatment of tuberculosis in adults and children

[9]

AQUINAS M, 1972, BRIT MED J, V1, P765

[10]

Badrinath M., 2023, StatPearls [Internet]

← 1 2 3 4 5 6 7 8 9 10 →